Trials / Completed
CompletedNCT00219700
Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial
Phase II, Randomized, Blinded Study of Ibuprofen-PC and Ibuprofen in Patients With Osteoarthritis to Investigate Efficacy and Gastrointestinal Toxicity
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 125 (planned)
- Sponsor
- PLx Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the safety and efficacy of 3 x 800 mg/day IBU-PC assessed by endoscopy and incidence of adverse events
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ibuprofen-PC |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2005-09-22
- Last updated
- 2008-11-26
Source: ClinicalTrials.gov record NCT00219700. Inclusion in this directory is not an endorsement.